Exane Derivatives Amarin Corp Plcuk Transaction History

Exane Derivatives

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 27, 2021	SELL	$4.04 - $5.31 $37,963 - $49,898	-9,397 Closed	0 $0
Q3 2020 Oct 06, 2020	SELL	$3.64 - $7.76 $1,179 - $2,514	-324 Reduced 3.33%	9,397 $39,000
Q2 2020 Jul 10, 2020	BUY	$4.78 - $8.26 $11,472 - $19,824	2,400 Added 32.78%	9,721 $67,000
Q1 2020 Apr 17, 2020	BUY	$4.0 - $21.53 $29,284 - $157,621	7,321 New	7,321 $29,000

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

Stay updated on Exane Derivatives with notifications on news.